Antifection

Pyralomicin 2a is an antibiotic that demonstrates significant antibacterial activity by targeting bacterial cell wall synthesis. It is primarily utilized in research to investigate its effectiveness against various bacterial strains and to explore its potential therapeutic applications in treating bacterial infections. This compound provides a valuable tool for studying antibiotic resistance and the mechanisms of action of antibacterial agents.

N-3-Hydroxydecanoyl-DL-homoserine lactone is a bacterial quorum-sensing molecule that primarily targets the transcription factor SdiA. It activates SdiA with an EC50 value of 0.6 µM, enabling the detection of N-acyl homoserine lactones (AHLs) in bacterial systems. This compound is particularly relevant for research into the regulation of gene expression in Salmonella enterica and other bacteria, providing insights into quorum sensing mechanisms and potential therapeutic strategies against bacterial infections.

Desertomycin B is an antibiotic derived from the guanidino form of a fermentation product of Streptomyces flavofungi. This compound exhibits potent antibacterial activity, demonstrating effectiveness against a range of gram-positive bacteria. Desertomycin B serves as a valuable tool in microbiological research and the study of antibiotic resistance mechanisms.

Celesticetin B is an antibiotic that primarily targets Gram-positive bacteria. It exhibits significant antibacterial activity, making it a valuable tool in the study of bacterial infections and resistance mechanisms. This compound is particularly useful for research focusing on the development of new therapeutic strategies against Gram-positive pathogens.

Hongoquercin A is a sesquiterpene antibiotic that exhibits moderate activity against Gram-positive bacteria, with a minimum inhibitory concentration (MIC) ranging from 4 to 8 μg/mL. This compound is valuable for research applications focused on antibiotic development and bacterial susceptibility studies. Its unique structure and mechanism of action make it a significant candidate for further exploration in microbial resistance and therapeutic interventions.

Lincosamine is a lincosamide antibiotic that inhibits bacterial growth through interference with protein synthesis. Produced by Streptomyces lincolnensis, Lincosamine demonstrates efficacy against various bacterial infections, particularly Klebsiella pneumoniae. Its activity has been benchmarked against other antimicrobial agents, highlighting its relevance in the study of bacterial resistance and the development of new therapeutic strategies.

Actiketal is a glutarimide antibiotic that primarily targets bacterial RNA synthesis. It demonstrates potent inhibition of [3H]thymidine incorporation in EGF-stimulated Balb/MK cells, indicating its potential effects on cell proliferation and differentiation. This compound is useful in research applications focused on understanding bacterial resistance mechanisms and exploring the role of antibiotics in cellular responses.

Cypemycin is a linaridin antibiotic that exhibits antitumor activity by inhibiting cancer cell proliferation. It demonstrates significant cytotoxicity against P388 leukemia cells, with an IC50 of 1.3 μg/mL. Additionally, Cypemycin is effective against various human tumor cell lines, including HeLa S3, HHCC-1, HCCS-M, and Slex, with IC50 values greater than 25 μg/mL. This compound serves as a valuable tool for researching cancer therapeutics and understanding mechanisms of tumor cell resistance.

Fluvirucin A1 is an antibiotic that specifically targets the influenza A virus. It exhibits potent antiviral activity, making it a valuable tool for researchers studying influenza infections and potential therapeutic interventions. Fluvirucin A1 can be utilized in preclinical studies to explore mechanisms of viral resistance and efficacy of antiviral compounds.

Monamycin G3 is an ester peptide antibiotic that primarily targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable reagent for investigating bacterial resistance mechanisms and evaluating the efficacy of antimicrobial agents in research settings. Its unique structure and mode of action make it an important tool for studies involving infection models and antibiotic development.

PF1140 is a fungal-derived antibiotic that exhibits potent antimicrobial activity against various infectious agents. It is primarily used in the study of infectious diseases, allowing researchers to investigate its efficacy and mechanisms of action. PF1140's unique properties make it a valuable tool for understanding antibiotic resistance and developing new therapeutic strategies.

Oxypyrrolnitrin is a nitrogen-containing heterocyclic antibiotic that exhibits broad-spectrum antibacterial and antifungal activity. It demonstrates efficacy against Gram-positive and Gram-negative bacteria, as well as mycobacteria and various fungi. This compound is valuable for research applications focused on combating bacterial resistance and studying fungal infections.

3-O-Demethylmonensin A is a polyether antibiotic that functions by disrupting ion transport across cell membranes, primarily targeting bacterial cells. This compound exhibits notable antibacterial activity and has been used in research to study antibiotic mechanisms and resistance. Its specific effects make it valuable for investigating microbial interactions and cellular processes in various biological systems.

Cefditoren Pivoxil hydrochloride is a third-generation oral cephalosporin antibiotic with broad-spectrum antibacterial activity, particularly effective against Gram-negative and Gram-positive bacteria. Its enhanced stability against various β-lactamases makes it a valuable tool in studying infectious diseases. Research applications include investigating acute exacerbations of chronic bronchitis, community-acquired pneumonia, streptococcal pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections.

Himalomycin A is an anthraquinone antibiotic that exhibits potent antibacterial activity against Staphylococcus aureus, Escherichia coli, and Streptomyces vuridochromogenes. Its mechanism of action involves interference with bacterial DNA synthesis and function, making it a valuable tool for studying antimicrobial resistance mechanisms and assessing bacterial susceptibility in research applications. This compound serves as a useful reagent for investigations in microbiology and antibiotic development.

Desmethyl ofloxacin hydrochloride is a primary metabolite of the fluoroquinolone antibiotic ofloxacin, targeting bacterial DNA gyrase and topoisomerase IV. This compound exhibits significant antibacterial activity against a variety of Gram-positive and Gram-negative bacteria. It is utilized in research to investigate mechanisms of antibiotic resistance and to explore the pharmacokinetics of fluoroquinolone antibiotics.

Oxamicetin is a nucleoside antibiotic targeting bacterial cell mechanisms. It exhibits potent anti-bacterial activity, particularly against mycobacteria, making it a valuable reagent for research focused on bacterial infections and resistance. Its unique properties facilitate studies in microbiology and contribute to the development of new therapeutic strategies.

Lincomycin B is an antibiotic derived from the bacterium Streptomyces lincolnensis. It exhibits potent antibacterial activity against a variety of Gram-positive bacteria, making it valuable for research in microbial pathogenesis and antibiotic resistance. Lincomycin B is often utilized in studies exploring microbial inhibition and the development of novel therapeutics.

Norvancomycin is a glycopeptide antibiotic derived from Nocardia orientalis, exhibiting potent antibacterial activity against various strains of Staphylococcus aureus and Staphylococcus epidermidis. This compound is primarily utilized in infection research, providing insights into antibiotic resistance mechanisms and potential therapeutic interventions. Its efficacy in combating Gram-positive bacterial infections makes it a valuable tool for microbiological and pharmacological studies.

Monamycin G2 is an ester peptide antibiotic that primarily targets Gram-positive bacteria. This compound exhibits significant antibacterial activity, making it a valuable tool for research into antibiotic resistance and the mechanisms of bacterial infection. Its unique structure and function position Monamycin G2 as a promising candidate for further studies in antibiotic development and microbiological applications.

Dactimicin is a pseudodisaccharide aminoglycoside antibiotic that specifically inhibits bacterial protein synthesis. It is effective against methicillin-susceptible Staphylococcus aureus and coagulase-negative staphylococci, demonstrating MIC50s of 2 μg/mL. Dactimicin retains activity against strains that produce aminoglycoside-modifying enzymes, making it a valuable reagent for research on antibiotic resistance and bacterial growth inhibition.

Saroaspidin B is an antibiotic compound featuring a dimeric structure derived from phloroglucinol. It exhibits significant antibacterial activity, making it a valuable reagent for studying microbial resistance and antibiotic efficacy. Research applications include investigating mechanisms of action against pathogenic bacteria and exploring potential therapeutic uses in infectious diseases.

Propeptin is a peptide antibiotic comprised of 19 amino acids, primarily targeting bacterial infections. It demonstrates selectivity by exhibiting weaker antibacterial activity against Pseudomonas aeruginosa, Mycobacterium monobacterium, and Xanthomonas oryzae. Although Propeptin does not affect KB and L1210 tumor cell lines, it effectively inhibits prolyl endopeptidase, suggesting potential applications in biochemical research and antibiotic development.

Sannamycin B is an aminoglycoside antibiotic that primarily targets bacterial ribosomes, inhibiting protein synthesis. While its antibacterial activity is limited to a few bacterial species, it serves as a valuable tool for studying antibiotic mechanisms and resistance. Sannamycin B can be utilized in research applications exploring the efficacy of aminoglycosides and the development of novel antimicrobial strategies.

Chrymutasin C is a glycosidic antibiotic known for its antitumor properties. It exerts cytotoxic effects on various cancer cell lines, making it a valuable compound for research applications in cancer treatment and drug development. Its efficacy in disrupting cellular processes highlights its potential as a therapeutic agent in oncology.

Cefpimizole sodium is a broad-spectrum cephalosporin antibiotic that targets bacterial cell wall synthesis. It is effective against a variety of Ampicillin-resistant bacteria and demonstrates significant activity against gram-negative species. In addition to its antimicrobial properties, cefpimizole sodium enhances the phagocytic activity of macrophages and neutrophils, making it valuable for research applications in microbiology and immunology.

(rac)-Methyl-6-gingerol is an antibiotic derived from Aframomum melegueta. This compound demonstrates significant anti-mycobacterial activity by inhibiting the efflux of toxins in Mycobacterium species. It serves as a valuable tool for research focused on combating mycobacterial infections and studying bacterial resistance mechanisms.

Seldomycin factor 5 is an aminoglycoside antibiotic with broad-spectrum antimicrobial activity. It disrupts bacterial protein synthesis by binding to the 30S ribosomal subunit, leading to misreading of mRNA and subsequent inhibition of bacterial growth. Seldomycin factor 5 is utilized in research applications focused on bacterial resistance mechanisms and the development of new antimicrobial therapies.

Platenomycin W2 is a macrolide antibiotic that targets bacterial ribosomes to inhibit protein synthesis, specifically effective against Gram-positive bacteria. Its bioactivity makes it a valuable tool in studying bacterial resistance mechanisms and developing new therapeutic agents against infections caused by resistant strains. Researchers can utilize Platenomycin W2 in antimicrobial susceptibility assays and studies focused on the molecular pathways of antibiotic action.

Polymyxin B is an antibiotic that primarily targets Gram-negative bacteria by binding with high affinity to lipopolysaccharides (LPS) in the bacterial cell wall. This binding disrupts membrane integrity, leading to increased permeability and ultimately inducing bacterial cell death. Polymyxin B is extensively utilized in research related to endotoxemia due to its ability to neutralize endotoxins and mitigate their harmful effects.

Lysostaphin targets the bacterial cell wall, acting as an antistaphylococcal agent. This enzyme exhibits the activities of glycylglycine endopeptidase, endo-β-N-acetyl glucosamidase, and N-acetyl muramyl-L-alanine amidase, leading to effective inhibition of Staphylococcus species. Due to its specific enzymatic action, lysostaphin is valuable in research focused on bacterial resistance, pathogen biology, and the development of antimicrobial therapeutics.

Moxifloxacin is an 8-methoxyquinolone antibiotic that functions through the inhibition of bacterial DNA gyrase and topoisomerase IV. It effectively targets a variety of Gram-positive and Gram-negative bacteria, making it useful in the treatment of conditions such as acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia. This compound is valuable for research involving antimicrobial resistance and bacterial infections in clinical microbiology studies.

Cefotaxime is a third-generation cephalosporin antibiotic that targets bacterial cell wall synthesis. It exhibits broad-spectrum antibacterial activity against a variety of Gram-positive and Gram-negative bacteria and is notably stable against β-lactamase enzymes. This compound is widely used in microbiological research and clinical settings for the treatment and study of bacterial infections.

Cefepime is a broad-spectrum cephalosporin antibiotic that effectively targets both Gram-positive and Gram-negative aerobic bacteria. It is characterized by its ability to penetrate the blood-brain barrier, making it suitable for treating central nervous system infections. While it exhibits potent antibacterial activity, it is important to note that cefepime has also been associated with neurotoxicity. This agent is utilized in various research applications focused on antibiotic resistance and infection control.

Trovafloxacin is a broad-spectrum quinolone antibiotic that primarily targets DNA gyrase and topoisomerase IV, exhibiting potent activity against Gram-positive, Gram-negative, and anaerobic bacteria. In addition to its antibacterial effects, Trovafloxacin is a selective inhibitor of the pannexin 1 channel (PANX1) with an IC50 of 4 μM, effectively modulating PANX1 inward current. Furthermore, Trovafloxacin influences cellular processes by inducing dysregulated fragmentation of apoptotic cells through PANX1 inhibition. This dual activity positions Trovafloxacin as a valuable reagent for research in microbiology and cell biology.

Surfactin is a cyclic lipopeptide biosurfactant exhibiting strong ionophoric activity by modulating the transport of mono- and divalent cations, such as calcium, across lipid bilayer membranes. This compound demonstrates significant antimicrobial properties, including antibacterial, antifungal, antimycoplasma, and hemolytic effects. Additionally, Surfactin possesses antiviral activity against various enveloped viruses, making it a valuable reagent for studies in microbiology, virology, and cell membrane research.

Cefoxitin is a cephalosporin-class antibiotic that exhibits strong stability against β-Lactamase. It demonstrates a broad spectrum of antibacterial activity, effective against both Gram-negative and Gram-positive bacteria. This compound is widely utilized in microbiological research and clinical studies focusing on antibiotic resistance and infection treatment.

Trovafloxacin mesylate is a broad-spectrum quinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, demonstrating potent activity against Gram-positive, Gram-negative, and anaerobic pathogens. Additionally, it serves as a selective and orally active inhibitor of the pannexin 1 channel (PANX1), with an IC50 of 4 μM for PANX1 inward current. Unlike other channels, Trovafloxacin mesylate does not affect connexin 43 gap junctions or PANX2, leading to potential therapeutic applications in the regulation of apoptosis by disrupting normal fragmentation of apoptotic cells through PANX1 inhibition.

Gastric mucin is a glycoprotein that acts as a bacterial inhibitor, particularly effective against Helicobacter pylori infection. It exhibits natural antibiotic properties and scavenges hydroxyl radicals, contributing to its protective role in the gastrointestinal tract. Gastric mucin plays a critical role in safeguarding against acid, proteases, and pathogenic microorganisms, while also providing defense against mechanical trauma. This functionality makes it a valuable reagent for research focused on gastrointestinal health and microbiome interactions.

G-418 is an aminoglycoside antibiotic that inhibits protein synthesis by binding to the ribosomal subunits, affecting both eukaryotic and prokaryotic cells. Its potent antibacterial properties make it a valuable tool in research applications such as the selection and maintenance of genetically modified cells, allowing for the study of gene function and expression. G-418 is widely utilized in molecular biology and cell culture workflows.

Piperacillin is a semisynthetic broad-spectrum β-lactam antibiotic that exerts bactericidal activity against a range of Gram-negative bacteria and select Gram-positive strains by targeting penicillin-binding proteins. This compound is frequently utilized in combination with the β-lactamase inhibitor Tazobactam to enhance its efficacy in clinical applications, particularly for treating infections caused by resistant bacteria. Its extensive antimicrobial profile makes it valuable for research in infectious disease and antibiotic resistance.

Cefazolin is a first-generation cephalosporin antibiotic that targets bacterial cell wall synthesis, inhibiting bacterial growth. It exhibits significant antibacterial activity against various gram-positive and some gram-negative bacteria, making it useful in research on bacterial infections. Additionally, Cefazolin has demonstrated anti-inflammatory properties, indicating potential applications in studies related to post-operative cognitive dysfunction (POCD).

Mecillinam, a β-lactam antibiotic, primarily targets bacterial cell wall synthesis by inhibiting penicillin-binding proteins in gram-negative organisms. It demonstrates a broad spectrum of antibacterial activity, making it valuable in studying bacterial infections and resistance mechanisms. Researchers often utilize Mecillinam for its effectiveness against various pathogenic strains, aiding in the development of therapeutic strategies and understanding bacterial physiology.

Fusidic acid is a bacteriostatic antibiotic derived from the fungus Fusidium coccineum, classified as a steroid. Its primary mechanism of action involves the inhibition of the release of translation elongation factor G (EF-G) from the ribosome, thereby suppressing bacterial growth. This compound is of particular interest in research focused on anticancer and anti-infective applications.

Zosurabalpin is a polypeptide antibiotic that targets the LPS transporter complex (LptB2FGC), effectively inhibiting the transport of lipopolysaccharides (LPS). This mechanism leads to the accumulation of endotoxins within cells, demonstrating significant antibacterial activity against Carbapenem-resistant Acinetobacter baumannii (CRAB). Zosurabalpin serves as a valuable tool for research in antibiotic resistance and bacterial infection mechanisms.

Pleuromutilin is a potent antibiotic that exerts its effects by inhibiting bacterial protein synthesis. This compound is effective against a variety of Gram-positive bacteria, making it a valuable tool in the study and treatment of antibiotic-resistant infections. Its specific mechanism of action targets the peptidyl transferase center of the ribosome, thereby disrupting essential bacterial cellular processes. Research applications include studies in microbiology, pharmacology, and infectious disease therapeutics.

Gramicidin S is a cationic cyclic peptide antibiotic that primarily targets bacterial cell membranes. It exhibits potent antibacterial activity by disrupting membrane integrity and inhibiting critical membrane protein functions, leading to cell death. The compound inserts into the phospholipid bilayer, specifically binding to negatively charged lipids, which interferes with cell division and wall synthesis. Additionally, Gramicidin S has been shown to inhibit ion channels, with IC50 values of 41 μM for Na+/K+-ATPase, 24 μM for tobacco leaf plasma membrane Mg2+/K+-ATPase, and 3 μM for rat heart plasma membrane Ca2+-ATPase, making it a valuable tool for research in microbiology and cell biology.

Lolamicin is an orally effective antibiotic that specifically targets the Gram-negative bacterial lipoprotein transport system, particularly the LolCDE complex. By competitively binding to lipoprotein binding sites, it inhibits the transmembrane transport of outer membrane lipoproteins, compromising the integrity of the bacterial outer membrane and resulting in cell death. Lolamicin demonstrates significant bactericidal and antibacterial activity against multidrug-resistant Enterobacteriaceae pathogens, including Escherichia coli and Klebsiella pneumoniae. This reagent is valuable for studying infections such as acute pneumonia and sepsis caused by Gram-negative bacteria.

Cecropin A is a linear antimicrobial polypeptide composed of 37 residues that exhibits potent antibacterial activity. Additionally, it demonstrates anticancer and anti-inflammatory properties, making it a valuable tool for research in infectious diseases, cancer therapy, and inflammatory response studies. Its ability to disrupt bacterial membranes can be leveraged in the development of novel antimicrobial agents.

Tebipenem is an orally available carbapenem antibiotic that exhibits broad-spectrum antibacterial activity against a variety of Gram-positive and Gram-negative bacteria, with the exception of Pseudomonas aeruginosa. It targets bacterial cell wall synthesis, making it a valuable tool in research focused on antimicrobial resistance and the development of new antibacterial therapies. Tebipenem is particularly relevant in studies aiming to characterize the pharmacodynamics and mechanisms of action of novel antibiotics.